Pharma industry needs a shot of GenAI to shift focus to value from volumes
Generative AI and data can propel India as a top player value-wise also, according to BioAsia and EY Parthenon
Generative AI and data can propel India as a top player value-wise also, according to BioAsia and EY Parthenon